Lorena Lupinacci

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Lorena Lupinacci

Oct 2, 2024, 15:14 | Blog

Suraj Samtani: Real-World Study of first Line Nivolumab plus Ipilimumab in Unresectable Pleural Mesothelioma

Suraj Samtani, Medical Oncologist at Harvard Medical School, shared a post on X, about recent…

Sep 26, 2024, 14:05 | Blog

Stephen V Liu: Real-world study of first-line nivolumab and ipilimumab for pleural mesothelioma

Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…

Aug 9, 2024, 05:53 | Blog

Nivolumab with and without ipilimumab in solid tumors of high mutational burden - Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer shared a post on X, about recent paper published in…

All: 3 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023